Crescent Biopharma (CBIO) Net Margin (2013 - 2026)
Crescent Biopharma (CBIO) posted quarterly Net Margin of 7341.87% for Q1 2026, up 58.5% quarter-over-quarter from 17690.09% in Q2 2022.
Crescent Biopharma (CBIO) Net Margin (2013 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has reported Net Margin for 8 consecutive years, with 7341.87% the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Margin changed N/A year-over-year to 7341.87%; the TTM figure through Jun 2026 stood at 22226.95% (changed N/A YoY), while the FY2025 annual figure was 1419.61%, changed N/A from the prior year.
- Net Margin grew to 7341.87% in Q1 2026 per CBIO's latest filing, from 17690.09% in the prior quarter.
- Across five years, Net Margin topped out at 7341.87% in Q1 2026 and bottomed at 17690.09% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 12.74% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -3.12% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -16.51% |
| 10 | Crescent Biopharma | 1.05 Bn | 875.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,341.87% |
| Jun 30, 2022 | -17,690.09% |
| Dec 31, 2021 | -98,847.07% |
| Sep 30, 2021 | -20,023.48% |
| Jun 30, 2021 | -10,140,324.65% |
| Mar 31, 2021 | -1,352.43% |
| Dec 31, 2020 | -9,551.50% |
| Sep 30, 2020 | -1,372.25% |
| Mar 31, 2020 | -85.14% |
| Sep 30, 2016 | -48,631.11% |
| Dec 31, 2015 | -136,605.83% |
| Sep 30, 2015 | -20,263.10% |
| Jun 30, 2015 | 51.95% |
| Jun 30, 2014 | 53.18% |
| Dec 31, 2013 | -39,167.15% |
| Sep 30, 2013 | -7,039.78% |
| Jun 30, 2013 | -6,349.75% |
| Mar 31, 2013 | 12.05% |